Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00996
|
|||||
Drug Name |
Ethopropazine
|
|||||
Synonyms |
10-(2-Diethylaminopropyl)phenothiazine; 10-[2-(Diethylamino)-1-Propyl]phenothiazine;10-[2-(Diethylamino)-2-methylethyl]phenothiazine; 10-[2-(Diethylamino)propyl]phenothiazine; 2-Diethylamino-1-propyl-N-dibenzoparathiazine; Aethopropropazin; Athapropazine; Athopropazin; Ethapropazine; Ethopromazine; Etopropezina; Fempropazine; Fenpropazina; Isopthazine; Isotazin; Isothazine; Isothiazine; Lysivane; N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine; N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine; N,N-diethyl-1-(10H-phenothiazin-10-yl)propan-2-amine; N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine; Parcidol; Pardidol; Parfezine; Parkin; Parkin (TN); Parkisol; Parsidan; Parsidan (TN); Parsidol; Parsidol(TN); Parsitan; Parsotil; Phenopropazine; Phenoprozine; Prodictazin; Prodierazine; Profenamina; Profenamina [INN-Spanish]; Profenamina [Italian]; Profenamine; Profenamine (INN); Profenamine [INN:BAN]; Profenaminum; Profenaminum [INN-Latin]; Prophenamine; Prophenaminum; RP 3356; Rochipel; Rocipel; Rodipal; SC 2538; SKF 2538; W 483
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antiparkinson Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C19H24N2S
|
|||||
Canonical SMILES |
CCN(CC)C(C)CN1C2=CC=CC=C2SC3=CC=CC=C31
|
|||||
InChI |
InChI=1S/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3
|
|||||
InChIKey |
CDOZDBSBBXSXLB-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 1094-08-2
|
|||||
Pharmaceutical Properties | Molecular Weight | 312.5 | Topological Polar Surface Area | 31.8 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
4.8
|
|||||
PubChem CID | ||||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.